GB-Swindon: UKRI - 1279 COVID Therapeutics response
Individual Reports of manufacturing and supply of specific drug candidates (to support UK CTAP) in the therapeutic response to COVID-19 Reports to be turned around in 4 days max in batches of 2-3 over a 2 month period. Additional information: Awarded under regulation 32 (2) (c) therapeutic response to Covid-19
Buyer
UK Research & Innovation (UKRI)
Value
£37
Published
25 Jan 2021
Closes
13 Jan 2021
Procurement details
Source
Contracts Finder
Region
Swindon
Procurement method
Not Specified
Category
Services
Contract starts
14 Jan 2021
Contract ends
15 Mar 2021
CPV classifications
73100000
Research and experimental development services
Lots
Lot default GB-Swindon: UKRI - 1279 COVID Therapeutics response
£37
Individual Reports of manufacturing and supply of specific drug candidates (to support UK CTAP) in the therapeutic response to COVID-19 Reports to be turned around in 4 days max in batches of 2-3 over a 2 month period. Additional information: Awarded under regulation 32 (2) (c) therapeutic response to Covid-19
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
25 Jan 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
Please follow this link to view the notice.
Not provided
Please follow this link to view the notice.
Tender notice
Contains public sector information licensed under the Open Government Licence v3.0.